Knoedler Leonard, Knoedler Samuel, Alfertshofer Michael, Hansen Frederik J, Schenck Thilo, Sofo Giuseppe, Obed Doha, Hollmann Katharina, Siegwart Laura C, Vollbach Felix H, Bigdeli Amir K, Kauke-Navarro Martin, Pomahac Bohdan
Department of Surgery, Division of Plastic Surgery, Yale School of Medicine, New Haven, CT, USA.
Instituto Ivo Pitanguy, Hospital Santa Casa de Misericórdia Rio de Janeiro, Pontifícia Universidade Católica do Rio de Janeiro, Rio de Janeriro, Brazil.
Aesthetic Plast Surg. 2024 Nov;48(22):4642-4650. doi: 10.1007/s00266-024-03927-0. Epub 2024 Mar 25.
The high prevalence of benign male breast tissue enlargement (gynecomastia) has resulted in a marked increase of gynecomastia cases. While about one third of male adults experience some form of gynecomastia, gynecomastia surgery (GS) outcome research is limited to small study populations and single-center/-surgeon databases. In this study, we aimed to access the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database to identify preoperative risk factors for complications and investigate postoperative outcomes of GS.
In this retrospective study, we queried the ACS-NSQIP database from 2008 to 2021 to identify male adult patients who underwent GS. Postoperative outcomes involved the occurrence of any, surgical and medical complications, as well as reoperation, readmission, and mortality within a 30-day postoperative time period. Univariable and multivariable assessment were performed to identify risk factors for complications while adjusting for possible confounders.
The study included 4,996 GS patients with a mean age of 33.7 ± 15 years and BMI of 28.2 ± 5.1 kg/m. White patients constituted 54% (n = 2713) of the cohort, and 27% (n = 1346) were obese. Except for 2020, there was a steady increase in GS cases over the study period. Outpatient surgeries were most common at 95% (n = 4730), while general surgeons performed the majority of GS (n = 3580; 72%). Postoperatively, 91% (n = 4538) of patients were discharged home; 4.4% (n = 222) experienced any complications. Multivariable analysis identified inpatient setting (p < 0.001), BMI (p = 0.023), prior sepsis (p = 0.018), and bleeding disorders (p = 0.047) as independent risk factors for complications.
In this study, we analyzed 4996 male adult GS patients from the ACS-NSQIP database, revealing an increased caseload and significant general surgeon involvement. Risk factors like bleeding disorders, inpatient status, and prior sepsis were linked to postoperative complications, while BMI was crucial for predicting adverse events. Overall, our findings may aid in enhancing patient care through advanced preoperative screening and closer perioperative management.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
男性乳腺组织良性增生(男性乳房肥大症)的高发病率导致男性乳房肥大症病例显著增加。虽然约三分之一的成年男性经历过某种形式的男性乳房肥大症,但男性乳房肥大症手术(GS)结果的研究仅限于小规模研究人群和单中心/单外科医生数据库。在本研究中,我们旨在访问美国外科医师学会国家外科质量改进计划(ACS-NSQIP)数据库,以确定并发症的术前危险因素,并调查GS的术后结果。
在这项回顾性研究中,我们查询了2008年至2021年的ACS-NSQIP数据库,以识别接受GS的成年男性患者。术后结果包括任何手术和医疗并发症的发生,以及术后30天内的再次手术、再次入院和死亡率。进行单变量和多变量评估以确定并发症的危险因素,同时对可能的混杂因素进行调整。
该研究纳入了4996例GS患者,平均年龄为33.7±15岁,BMI为28.2±5.1kg/m²。白人患者占队列的54%(n=2713),27%(n=1346)为肥胖患者。除2020年外,研究期间GS病例稳步增加。门诊手术最为常见,占95%(n=4730),而普通外科医生实施了大部分GS手术(n=3580;72%)。术后,91%(n=4538)的患者出院回家;4.4%(n=222)出现任何并发症。多变量分析确定住院环境(p<0.001)、BMI(p=0.023)、既往败血症(p=0.018)和出血性疾病(p=0.047)为并发症的独立危险因素。
在本研究中,我们分析了ACS-NSQIP数据库中的4996例成年男性GS患者,发现病例数量增加且普通外科医生参与度较高。出血性疾病、住院状态和既往败血症等危险因素与术后并发症相关,而BMI对于预测不良事件至关重要。总体而言,我们的研究结果可能有助于通过先进的术前筛查和更密切的围手术期管理来加强患者护理。
证据水平III:本刊要求作者为每篇文章指定证据水平。有关这些循证医学评级的完整描述,请参阅目录或在线作者指南www.springer.com/00266。